Mission Statement
To manage costs, improve outcomes, and enhance the quality of life for individuals with
chronic health conditions.
Corporate Overview
Chronimed is a diversified healthcare company focusing on the needs of people with chronic
conditions. We develop, market, and distribute pharmaceuticals, medical products, and other
specialized services for people with long-term conditions such as diabetes, HIV/AIDS, organ
transplants, and select diseases treated with self-injectable drugs. Using our in-house distribution
systems as well as our specialty pharmacy centers, we dispense medications and products directly to
individuals, including patients of managed care organizations, and to institutions that serve
our patients.
By specializing in high-cost, high risk health conditions, Chronimed is well-positioned in today's
payor-driven system which values cost containment and improved outcomes. We believe our continued
success rests on a strong infrastructure that supports the entire company. Many employees receive
extensive training and competency testing to ensure expert service for patients and customers.
Advanced computer and telecommunications systems allow us to efficiently deliver specialized products
and services throughout the United States and other countries. And quality facilities provide the
flexible foundation for current and future activities.
History Timeline
Chronimed Chronology
- Founded in 1985 as The Diabetes Center, Inc.
- 1980s - Focused on diabetes products distribution
- 1990 - Started organ transplant specialty pharmacy
- 1991 - Launched proprietary diabetes products
- 1992 - IPO
- 1994 - Conducted pilot for self-injectables
- 1996 - Acquired StatScript Pharmacy
- 1997 - Revenue exceeded $100 million